MarketReview reviews Medigap companies at the company level, not as though one insurance carrier offers a single national policy at one national price. Medigap benefits are standardized by plan letter in most states, while premiums, discounts, underwriting, issuing companies and availability can vary by location and applicant. Our methodology is built around that distinction.
The purpose of a MarketReview Medigap Rating is to help readers decide which companies deserve closer investigation after they understand the Medigap plan design they want. It is not a substitute for a current quote, an underwriting decision or state-specific policy documents.
We review the company around the standardized policy
In most states, Medigap plans with the same letter provide the same standardized basic benefits regardless of which insurance company sells the policy. That changes what a useful company review should measure.
We do not give one Plan G company extra credit by pretending its standardized Plan G medical benefits are richer than another insurer's Plan G. The same principle applies to Plan N and other standardized letters. Instead, we focus on the differences that remain after the benefit design is fixed.
Those differences can include the premium a consumer is quoted, how the policy is priced, the availability and durability of discounts, company service, complaint context, the insurer behind the policy, state availability and the practical difficulty of changing companies later.
This approach keeps the rating focused on what the company can actually influence. The plan letter determines the standardized benefits. The insurance company determines much of the ownership experience around those benefits.
Pricing matters, but we do not use one national premium
Price is one of the most important Medigap comparison factors because two companies can charge very different premiums for the same standardized plan letter. A higher premium does not buy a richer standardized Plan G or Plan N benefit package.
At the same time, Medigap pricing is not safely reduced to one national number. Premiums can differ by state, age, tobacco status, household circumstances, enrollment timing, rating method, underwriting and discounts. A company that is competitive for one applicant can be expensive for another.
For that reason, MarketReview does not assign a company rating by taking one sampled premium and treating it as the carrier's nationwide price. We use verified state-specific evidence to understand how a company participates in the Medigap market, but the rating reflects broader company-level judgment rather than one local quote.
When price-focused evidence is material to a review or Best page, we state the geographic scope. Readers should still request current quotes for the same plan letter using the same applicant information before choosing a policy.
We consider how the policy is priced over time
The opening premium is only part of the cost decision. Medigap policies can use community-rated, issue-age-rated or attained-age-rated pricing, subject to state rules and insurer practices.
These methods affect how age enters the premium, but none guarantees that the price will remain unchanged. Inflation, claims experience, approved rate changes and other permitted factors can still affect premiums.
We therefore consider pricing structure as context rather than treating one rating method as automatically superior. A competitive attained-age policy can still offer strong value. An issue-age policy can still become expensive. The relevant question is whether the company's current pricing, rate structure and long-term ownership proposition make sense together.
We do not claim to predict future rate increases. Historical or current rate information can inform editorial judgment where reliable evidence exists, but it is not presented as a guarantee of future pricing.
Discounts are part of the value assessment
Household discounts, automatic-payment savings, non-tobacco rates and other permitted discounts can materially affect the cost of Medigap coverage. Because standardized benefits do not become weaker when a valid discount lowers the premium, durable discounts can be meaningful company differentiators.
We look beyond the advertised percentage. A large discount applied to a high base premium can still result in a more expensive policy than a competitor's smaller discount or undiscounted rate.
Where discount information is included in our analysis, we consider the conditions required to receive and keep the discount. We also keep state-specific evidence scoped to the state where it was verified. A discount available through one issuing company or jurisdiction is not automatically treated as a nationwide company feature.
Availability is treated as state-specific evidence
A Medigap company can operate across many states without offering every standardized plan everywhere. The legal insurer used by a brand can also differ by jurisdiction.
MarketReview does not infer nationwide availability from the size of an insurance company. Our canonical Medigap inventory uses representative state evidence for the current editorial build rather than attempting to maintain an exhaustive rate and availability database for every state.
When our evidence confirms that a plan is available in a representative state, we can state that clearly within that scope. When national availability has not been established, we use language such as “varies by state” rather than treating missing evidence as proof that a plan is unavailable.
Massachusetts, Minnesota and Wisconsin also use different Medigap standardization systems from the federal lettered structure used in most other states. Our analysis does not force those state-specific systems into a Plan G or Plan N framework that does not accurately describe them.
We distinguish the consumer brand from the legal insurer
The company name a consumer recognizes is not always the legal insurance company that issues the policy. Large insurance groups can use different subsidiaries in different states, and association-branded products can involve separate marketing and underwriting entities.
Our Medigap data model keeps those roles separate when reliable evidence supports the distinction. A review can evaluate the consumer-facing company while also identifying the insurer responsible for the representative policy evidence used in our research.
This distinction matters because regulatory filings, complaint records, premium filings and policy obligations may belong to the legal insurer rather than the marketing brand.
We do not assume that one issuing company identified in a representative state is the issuer used by the brand everywhere.
Complaint and service evidence inform the rating, but no single metric controls it
Service quality matters because Medigap is often held for many years. Billing, policy administration, rate notices, claims coordination and customer support can affect the ownership experience even when the standardized medical benefits are identical.
Where reliable regulatory complaint information or other authoritative service evidence is available, we use it as part of the broader assessment. We also consider meaningful limitations visible in the company's operating model or current policy evidence.
No single complaint ratio, survey result or third-party score automatically determines the MarketReview Rating. Different data sources measure different populations, time periods and entities. A legal insurer's complaint experience, for example, should not be silently treated as a permanent score for every affiliate under the same consumer brand.
We use these signals to support editorial judgment, not to manufacture a mechanical formula.
Enrollment and underwriting affect how much the company choice matters
Medigap differs from products that consumers can freely replace every year without health review. During the federal Medigap Open Enrollment Period, consumers receive important protections when buying available Medigap coverage. Outside protected situations, medical underwriting may apply unless a guaranteed issue right or additional state protection is available.
That makes long-term company fit relevant to our reviews. A small first-year premium advantage can matter, but so can the possibility that switching later may be more difficult.
We consider this context when assessing pricing, discounts and ownership risk. We do not assume that a consumer who dislikes a future rate increase will always be able to move immediately to another company on the same terms.
Underwriting decisions themselves remain applicant-specific. A MarketReview Rating does not indicate that a particular consumer will be accepted, declined or charged a particular premium.
Plan G, Plan N and high-deductible Plan G are evaluated in the correct context
A company can appear on several MarketReview Medigap Best pages while retaining one authoritative company-level rating. The rating does not change simply because the editorial question changes.
What can change is the Best For designation and ranking context. A company may stand out more strongly for Plan G than for Plan N, or it may deserve particular attention for high-deductible Plan G or household discounts.
Those distinctions belong to the Best-page ranking rather than the underlying company rating.
Plan G, Plan N and high-deductible Plan G also represent different consumer decisions. We do not compare them as though the only difference is the insurance company. Plan design comes first. Company comparison comes second.
MarketReview Ratings are editorial judgments, not a weighted scoring formula
MarketReview Ratings reflect our editorial assessment of a Medigap company based on the evidence relevant to the consumer decision. We do not assign artificial percentage weights to pricing, complaints, discounts, service, availability or other factors.
A rigid weighted formula could create false precision, especially in Medigap where many important facts vary by state and applicant. Instead, the rating reflects the strength of the evidence, the importance of each factor to the consumer and the material limitations identified during research.
We distinguish verified facts from editorial judgment. A verified Plan G offering in a representative state is a factual input. Whether the company's overall pricing and ownership proposition makes it one of the stronger Medigap companies is an editorial conclusion.
The formal reasoning supporting an individual company's rating is maintained in the review's rating rationale. The visible review body focuses on helping readers understand the company rather than repeatedly defending a numerical score.
We use primary and authoritative evidence wherever possible
Research for Medigap reviews prioritizes authoritative sources such as Medicare, state insurance regulators, official insurance company materials, policy outlines, rate or plan availability documents and legal insurer disclosures.
Competitor publications can help identify useful consumer questions, but they are not treated as authority for current premiums, plan availability, discounts, underwriting or policy terms.
When reliable sources conflict, we prefer the most specific and current evidence available. If an important fact cannot be verified confidently, we qualify the claim, leave it out or state the uncertainty rather than filling the gap with an assumption.
Representative state evidence is never silently expanded into a national claim.
How to use a MarketReview Medigap Rating
The rating is designed to help prioritize research. A company with a stronger rating may deserve an earlier place on your shortlist, but the number should not decide the policy by itself.
After narrowing the field, compare current quotes for the same standardized plan letter in your state. Confirm the legal insurer, final premium, discounts, pricing method, underwriting requirements and policy type. If you are considering high-deductible Plan G, compare it separately from standard Plan G.
The final choice should combine two decisions: the Medigap plan design that fits how you want Original Medicare costs handled, and the company that offers that design to you at a competitive price under terms you understand.
That is the role of the MarketReview Rating. It helps identify companies worth investigating. The state-specific policy and quote determine whether one of them is right for you.